SLU researcher wins $4.5 million in grants to study side effects of chemo, opioids
A Saint Louis University scientist will use $4.5 million in grant money from the National Institutes of Health for separate studies on the side effects of chemotherapy and those from opioids. Daniela Salvemini, a SLU professor of pharmacology and physiology who focuses on pain research, will use a more than $2.8 million NIH grant to study chemotherapy-induced cognitive impairment (CICI), or so-called "chemo-brain," that can be experienced by cancer patients. CICI is a major neurotoxi c side effect… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 23, 2018 Category: American Health Authors: Diana Barr Source Type: news

SLU researcher wins $4.5 million in grants to study side effects of chemo, opiods
A Saint Louis University scientist will use $4.5 million in grant money from the National Institutes of Health for separate studies on the side effects of chemotherapy and those from opioids. Daniela Salvemini, a SLU professor of pharmacology and physiology who focuses on pain research, will use a more than $2.8 million NIH grant to study chemotherapy-induced cognitive impairment (CICI), or so-called "chemo-brain," that can be experienced by cancer patients. CICI is a major neurotoxi c side effect… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 23, 2018 Category: Biotechnology Authors: Diana Barr Source Type: news

SLU researcher wins $4.5 million in grants to study side effects of chemo, opiods
A Saint Louis University scientist will use $4.5 million in grant money from the National Institutes of Health for separate studies on the side effects of chemotherapy and those from opioids. Daniela Salvemini, a SLU professor of pharmacology and physiology who focuses on pain research, will use a more than $2.8 million NIH grant to study chemotherapy-induced cognitive impairment (CICI), or so-called "chemo-brain," that can be experienced by cancer patients. CICI is a major neurotoxi c side effect… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 23, 2018 Category: Health Management Authors: Diana Barr Source Type: news

Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
HENDERSON, Nev.--(BUSINESS WIRE)--Oct. 23, 2018-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 23, 2018 Category: Drugs & Pharmacology Source Type: news

We must keep antibiotics working, says RPS President
RPS President Ash Soni talked to LBC radio today about the threat of antibiotic resistance at the start of Public Health England’s latest campaign, Keep Antibiotics Working. PHE’s annual (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 23, 2018 Category: Drugs & Pharmacology Source Type: news

Epanutin (phenytoin) 30mg/5ml oral suspension -supply disruption
The Department of Health& Social Care (DHSC) has issued a supply disruption alert for Epanutin (phenytoin) 30mg/5ml oral suspension. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 23, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England welcomes criteria change to practice pharmacist programme
Commenting on the change in the application criteria to make it easier for GP practices to apply for co-funding for a practice pharmacist, RPS Board Chair Sandra Gidley said:“Wherever they pra (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 23, 2018 Category: Drugs & Pharmacology Source Type: news

MHRA Update: Valproate Pregnancy Prevention Programme - an update for pharmacists
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a letter for pharmacists as a reminder of the importance of the Valproate Pregnancy Prevention Programme, which was communicat (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 23, 2018 Category: Drugs & Pharmacology Source Type: news

Zebrafish gravitate to higher levels
Zebrafish could help scientists understand the early stages of diseases such as osteoarthritis after spending time in hypergravity to investigate how their development is affected by increased loading conditions. Postgraduate students from the University of Bristol completed their study at the European Space Agency (ESA) European Space Research and Technology Centre last month. (Source: University of Bristol news)
Source: University of Bristol news - October 22, 2018 Category: Universities & Medical Training Tags: Current students, International, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Physiology, Pharmacology and Neuroscience; Press Release Source Type: news

Community Pharmacy funding settlement for 2018-19
Responding today to PSNC’s announcementthat community pharmacy funding levels will be maintained for 2018/19 at£2.592bn,Paul Bennett, RPS Chief Executive said:“We completely under (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 22, 2018 Category: Drugs & Pharmacology Source Type: news

Unsure about using the Summary Care Record?
We’ve heard from you that you don’t always know how and when to use the summary care record. Our updated guidance answers all your concerns. It also helps you understand how using the rec (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 22, 2018 Category: Drugs & Pharmacology Source Type: news

Talzenna (Talazoparib Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 22, 2018 Category: Drugs & Pharmacology Source Type: news

Cardiovascular Damage in Patients With HCV Cirrhosis Cardiovascular Damage in Patients With HCV Cirrhosis
This study investigated the prevalence of early signs of cardiovascular damage in patients with HCV cirrhosis. Is such damage reversible following treatment with DAAs?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
PARIS and TARRYTOWN, N.Y., Oct. 19, 2018 /PRNewswire/ -- Sanofi (EURONEXT: SAN) (NYSE: SNY) The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 19, 2018 Category: Drugs & Pharmacology Source Type: news

Flucelvax Quadrivalent 2018-2019 Formula (Influenza Vaccine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 19, 2018 Category: Drugs & Pharmacology Source Type: news

FluMist 2018-2019 Formula (Influenza Vaccine Intranasal) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 19, 2018 Category: Drugs & Pharmacology Source Type: news

Taxotere (Docetaxel for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 19, 2018 Category: Drugs & Pharmacology Source Type: news

Ondansetron Hydrochloride Injection (Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 18, 2018 Category: Drugs & Pharmacology Source Type: news

Diltiazem Hydrochloride ER (Twice-a-Day) Capsules (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 18, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Fellows interviewed by BBC1's Rip Off Britain
RPS Fellows Professors Jayne Lawrence and Theo Raynor have featured in BBC 1’s Rip Off Britain talking about branded and generic medicines. Interviewed by a patient, Jayne and Theo said that br (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 18, 2018 Category: Drugs & Pharmacology Source Type: news

ViiV Healthcare Submits New Drug Application to FDA for Single-Tablet, Two-Drug Regimen of Dolutegravir and Lamivudine for Treatment of HIV
London - 18 October 2018 ViiV Healthcare today announced it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for a single-tablet, two-drug regimen of dolutegravir (DTG) and lamivudine (3TC) for the treatment of... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 18, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Advisory Committee Recommends Approval of Shire ’s Prucalopride (SHP555) for Chronic Idiopathic Constipation
Cambridge, Mass. – October 18, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee voted unanimously (10 to 0) that the risk-benefit profile of... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 18, 2018 Category: Drugs & Pharmacology Source Type: news

UPDATED MEETING TIMES AND PUBLIC PARTICIPATION INFORMATION: October 24-25, 2018: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement
October 24-25, 2018: Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 17, 2018 Category: Drugs & Pharmacology Source Type: news

Interim dispensing protocol on dispensing of adrenaline auto-injectors, 150microgram.
The Department of Health& Social Care (DHSC) has issued an interim dispensing protocol on dispensing of adrenaline auto-injectors, 150microgram. This validation protocol has been developed to (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 17, 2018 Category: Drugs & Pharmacology Source Type: news

Flublok Quadrivalent 2018-2019 (Influenza Vaccine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 17, 2018 Category: Drugs & Pharmacology Source Type: news

Fluarix Quadrivalent 2018-2019 (Influenza Vaccine) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 17, 2018 Category: Drugs & Pharmacology Source Type: news

Ellzia Pak (Triamcinolone Acetonide Ointment ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 17, 2018 Category: Drugs & Pharmacology Source Type: news

Use of Different PPIs and Microscopic Colitis Use of Different PPIs and Microscopic Colitis
This study examined the impact of timing, dose and choice of PPI.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
On October 16, 2018, the Food and Drug Administration approved talazoparib (Talzenna, Pfizer Inc.), a poly (ADP-ribose) polymerase (PARP) inhibitor, for patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm),... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for KPI-121 0.25% for Dry Eye Disease
WALTHAM, Mass.--(BUSINESS WIRE)--Oct. 16, 2018-- Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for KPI-121 0.25%, a topical... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

Biosimilars set to benefit patients and the NHS
Today marks the European patent expiry for the biologic Adalimumab (Humira), which is prescribed in hospitals for conditions including rheumatoid arthritis, inflammatory bowel disease and psoriasis. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

Adalimumab (Humira)
Title: Adalimumab (Humira)Category: MedicationsCreated: 10/16/2018 12:00:00 AMLast Editorial Review: 10/16/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced today that the U. S. Food... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

Scopolamine Transdermal System (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

Eflornithine Hydrochloride (Vaniqa) Cream (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

Sterile Water (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

Stavudine (Zerit) Powder for Oral Solution (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

Prevalence of Celiac Disease in Patients With Osteoporosis Prevalence of Celiac Disease in Patients With Osteoporosis
Are individuals with celiac disease at increased risk for osteoporosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

RPS England talks to media about medical exemption fines
RPS England Board members were out in force on TV and radio yesterday in response to Government plans to strengthen checks at pharmacies for entitlement to free prescriptions in England. This include (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

NHS England – Junior Epipen shortage
NHS England has issued a letter for parents and guardians of children who use Epipen Junior. This letter will be shared through GPs. The supply problem is expected to last several months. Pharmacists (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 15, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
REDWOOD CITY, Calif., Oct. 12, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, announced today that the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

CAM Popular, but Cancer Patients Unaware of Risks CAM Popular, but Cancer Patients Unaware of Risks
Two studies involving sarcoma patients show that complementary and alternative medicine (CAM) treatments are popular, and most patients seem to be unconcerned about risks, such as interactions.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 12, 2018 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

New Education Governance Oversight Board will lead Postgraduate training for pharmacy
The Royal Pharmaceutical Society (RPS) hosted the first meeting of a new Education Governance Oversight Board (EGOB) to lead postgraduate training for pharmacy across the UK, on September 27th 2018. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

MHRA Drug Safety Update: Life-threatening and fatal opioid toxicity from accidental exposure to transdermal fentanyl patches, particularly in children
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update regarding transdermal fentanyl patches: life-threatening and fatal opioid toxicity from accidental exposu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

Tegsedi (Inotersen Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

Hemlibra (Emicizumab-Kxwh Injection, for Subcutaneous Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

Revcovi (Elapegademase-lvlr) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 12, 2018 Category: Drugs & Pharmacology Source Type: news

Natural remedy for colon cancer found in this "warm" TCM herb
(Natural News) The pharmacology of traditional Chinese medicine (TCM) is based on re-establishing balance to the body through various herbs and plants. “Warm” plants such as the Lycopus lucidus (known in TCM as ze lan) are typically prescribed to treat “cold” conditions such as cancer. A study published in Evidence-Based Complementary and Alternative Medicine determined... (Source: NaturalNews.com)
Source: NaturalNews.com - October 12, 2018 Category: Consumer Health News Source Type: news

Ondansetron Hydrochloride Injection (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - October 11, 2018 Category: Drugs & Pharmacology Source Type: news